Prof. Dr. med.

Rossi Davide

Viceprimario

Lingue parlate:

Italiano, inglese

Informazioni sul medico

Iter professionale
  • Medico caposervizio, Ematologia, Istituto Oncologico della Svizzera Italiana, EOC

  • Dirigente Medico, Ematologia, Ospedale Maggiore della Carità, Novara, Italia

  • Professore Assistente, Ematologia, Università del Piemonte Orientale, Novara, Italia

  • Medico borsista, Ematologia, Ospedale Maggiore della Carità di Novara, Italia

  • Medico Specializzando in Medicina Interna, Ospedale Maggiore della Carità, Novara, Italia

Specializzazioni e formazione
Specializzazioni
  • 2020 - FMH Specializzazione in Ematologia
  • 2009 - PhD in Medicina Clinica e Sperimentale, Università del Piemonte Orientale, Novara, Italia
  • 2005 - Specializzazione in Medicina Interna, Università del Piemonte Orientale, Novara, Italia
  • 2000 - Laurea in Medicina e Chirurgia, Università del Piemonte Orientale, Novara, Italia
     
Attività didattica
  • Professore Associato, Facoltà di Biomedicina, Università della Svizzera Italia, Lugano (2020)
  • Italian Society of Hematology young investigator prize (2009)
  • Professore Assistente di Ematologia, Università del Piemonte Orientale, Novara, Italia (2008 - 2015)
  • Accademia Nazionale dei Lincei - "Silvia Fiocco" young investigator prize for the research in the field of lymphomas and leukemias (2011)
  • Federico Calabresi Foundation prize for the best hematologic paper in 2011
  • "Under 40 Hematology" young investigator prize for the research in the field of hematology (2012)
  • Pfizer Research Prize for the research in the field of hematology (2017)
  • Ellermann Prize of the Swiss Society of Hematology (2019)
  • Rober Wenner Award, Swiss Cancer League (2021)
  • 12th International Conference on Malignant Lymphoma, Meet the Professor. Lugano (2013)
  • 19th Congress of the European Hematology Association. Hematology-in-Focus session: Novel recurrent mutations in CLL. Milan (2014)
  • 56th Annual Meeting of The American Society of Hematology, Educational Session: Role of MYD88 mutation in lymphoplasmacytic lymphoma diagnosis and pathogenesis. San Francisco (2014)
  • 13th International Conference on Malignant Lymphoma, Educational Symposium: Histological transformation in lymphoma. Lugano (.2015)
  • 21st Congress of the European Hematology Association. Educational Session on CLL: Prognostic and predictive factors in the era of new targeted therapies. (Copenhagen, 2016)
  • XVII International Workshop on Chronic Lymphocytic Leukemia (iwCLL), session on Strategies for the Evaluation and Treatment of CLL in the Front-line Setting: “Clinical Approach to the Diagnosis and Initial Evaluation of a CLL Patient” (New York City, US, 2017)
  • 23rd Congress of the European Hematology Association, Hematology-in-Focus: Liquid biopsy in hematology: “Liquid biopsy in lymphoma” (Stockholm, Sweden, 2018)
  • ESMO 2019 Congress, Special symposium on Biology and early diagnosis of blood malignancies: Early molecular and computational diagnostics by liquid biopsies (Barcelona, 2019)
  • 62th Annual Meeting of The American Society of Hematology, Scientific Program Session: Getting the Most from Minimal Residual Disease: “Use of Minimal Residual Disease and Advances in Clinical Trials” (Virtual, 2020)
  • Plenary Scientific Session "introducer" at the 63rd ASH Annual Meeting of The American Society of Hematology (Atlanta, 2021)

Affiliazioni

  • ASH - American Society of Hematology
  • EHA - European Hematology Association
  • ERIC - European Research Initiative on CLL
  • Member of the Editorial Board of Blood and Blood Cancer Discovery
  • iwCLL - International Workshop on Chronic Lymphocytic Leukemia
  • ICML - Organizing Committee, International Conference on Malignant Lymphoma
  • Member of the Scientific Program Committee, Congress of the European Hematology Association (2017 - 2021)
  • ESMO 
Pubblicazioni
Autore di pubblicazioni scientifiche nazionali e internazionali, su riviste peer reviewed e libri di testo.
Le pubblicazioni sono disponibili su: